Investigation Report on China Imipenem and cilastatin sodium Market, 2010-2019

June 2015 | 30 pages | ID: IC84A8291AAEN
China Research and Intelligence Co., Ltd.

Abstracts

Description

Coming into being in the 1980s, penem is an unsatured ?-lactam featuring broad spectrum, strong effect and low resistance rate. Actually it is the most potent antibiotic with the broadest antibacterial spectrum hitherto. And Imipenem cilastatin is one of the commercially available penem class.

Developed by Merck & Sharp Dohme (US) in 1979, imipenem and cilastatin sodium is the most famous one in imipenem cilastatin class. Its sales value around the world was USD 610 million in 2011 and USD 520 million in 2012, down 25.4% year-on-year. And imipenem and cilastatin sodium is used for the treatment of mixed infection caused by a variety of pathogens and aerobic or anaerobic bacteria as well as the early treatment before pathogens are identified.

Imipenem and cilastatin sodium develops fast after entering China with annual sales value rising from less than CNY 200 million in 2005 to CNY 595 million in 2014 and CAGR during this period reaching 15.6%. Currently, imipenem and cilastatin sodium in the Chinese market mainly come from the following companies: Merck & Sharp Dohme (US), United Laboratories, RANBAXY LABORATORIES LTD(ID) and Shenzhen Haibin Pharmaceutical Co., Ltd, among which Merck & Sharp Dohme (US) has the largest market share of 90% for sales value in 2014.

As the development programs and manufacturers of penem antibiotics increase, the market competition will become more and more severe in future. The market size of imipenem and cilastatin sodium is expected to keep expanding in the next few years in China.

Readers can get at least the following information from this report:

• market size of imipenem and cilastatin sodium in China
• competitive landscape of imipenem and cilastatin sodium in Chinese market
• price of imipenem and cilastatin sodium made by different enterprises in China
• market outlook of imipenem and cilastatin sodium in China

The author suggests the following groups of people purchase this report:

• manufacturers of anti-infective drugs
• investors/ research institutions interested in Chinese medicine market
• any interest in the Chinese medicine market, please contact CRI for customized survey service

Contents

1 RELATED CONCEPTS OF IMIPENEM AND CILASTATIN SODIUM

1.1 Indication
1.2 Sales Status in Global Market

2 MARKET PROFILE OF IMIPENEM AND CILASTATIN SODIUM IN CHINA

2.1 Patent and Approval Status of Imipenem and cilastatin sodium in China
2.2 Major Manufacturers
2.3 MARKET SIZE

3 SURVEY ON SALES STATUS OF IMIPENEM AND CILASTATIN SODIUM IN CHINA, 2010-2014

3.1 Sales Value
  3.1.1 Overall Sales Value
  3.1.2 Sales Value by Regions
3.2 Sales Volume
  3.2.1 Overall Sales Volume
  3.2.2 Sales Volume by Regions

4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF IMIPENEM AND CILASTATIN SODIUM IN CHINA, 2010-2014

4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 SURVEY ON DOSAGE FORMS OF IMIPENEM AND CILASTATIN SODIUM IN CHINA, 2010-2014

5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 REFERENCE PRICE OF IMIPENEM AND CILASTATIN SODIUM IN CHINESE HOSPITALS IN 2014

6.1 RANBAXY LABORATORIES LTD(ID) (Trade Name: Bacqure)
6.2 Choongwae Pharma Corporation Korea(Trade Name: Prepenemtm)
6.3 China National Medicines Guorui Pharmaceutical Co., Ltd (Trade Name: Kaluoxin)
6.4 Yungjin Pharm. Co., Ltd (KE)
6.5 Hisun Pfizer Pharmaceutical Co., Ltd
6.6 Shenzhen Haibin Pharmaceutical Co., Ltd (Trade Name: Beineng)
6.7 United Laboratories
6.8 Merck & Sharp Dohme (US) (Trade Name: Tienam)

7 MAJOR MANUFACTURERS OF IMIPENEM AND CILASTATIN SODIUM IN CHINESE MARKET, 2010-2014

7.1 Merck & Sharp Dohme (US)
7.2 United Laboratories
7.3 Hisun Pfizer Pharmaceutical Co., Ltd
7.4 Shenzhen Haibin Pharmaceutical Co., Ltd
7.5 RANBAXY LABORATORIES LTD(ID)
7.5 RANBAXY LABORATORIES LTD(ID)

8 MARKET OUTLOOK OF IMIPENEM AND CILASTATIN SODIUM IN CHINA, 2015-2019

8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

TABLE OF SELECTED CHARTS

Chart Approval Information of Imipenem and cilastatin sodium in China
Chart Sales Status of Imipenem and cilastatin sodium in China, 2010-2014
Chart Sales Value of Imipenem and cilastatin sodium in China, 2010-2014
Chart Sales Value of Imipenem and cilastatin sodium in Some Regions in China, 2010-2014
Chart Sales Volume of Imipenem and cilastatin sodium in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Imipenem and cilastatin sodium for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Imipenem and cilastatin sodium Made by Merck & Sharp Dohme (US) in China, 2010-2014
Chart Sales Value and Market Share of Imipenem and cilastatin sodium Made by Hisun Pfizer Pharmaceutical Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Imipenem and cilastatin sodium Made by United Laboratories in China, 2010-2014
Chart Sales Value and Market Share of Imipenem and cilastatin sodium Made by RANBAXY(ID) in China, 2010-2014
Chart Price of Imipenem and cilastatin sodium Made by RANBAXY LABORATORIES LTD(ID) in Some Chinese Cities in 2014
Chart Price of Imipenem and cilastatin sodium Made by Choongwae Pharma Corporation Korea in Some Chinese Cities in 2014
Chart Price of Imipenem and cilastatin sodium Made by China National Medicines Guorui Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Imipenem and cilastatin sodium Made by Yungjin Pharm. Co., Ltd (KE) in Some Chinese Cities in 2014
Chart Price of Imipenem and cilastatin sodium Made by Hisun Pfizer Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Imipenem and cilastatin sodium Made by Shenzhen Haibin Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Imipenem and cilastatin sodium Made by United Laboratories in Some Chinese Cities in 2014
Chart Price of Imipenem and cilastatin sodium Made by Merck & Sharp Dohme (US) in Some Chinese Cities in 2014